Navigation Links
Blood Glucose Testing and Diabetes Management - Dramatic Increase in the Incidence of Diabetes
Date:4/2/2013

DUBLIN, April 2, 2013 /PRNewswire/ --

Research and Markets has announced the addition of the "Blood Glucose Testing and Diabetes Management" report to their offering.

     (Photo: http://photos.prnewswire.com/prnh/20130307/600769 )

There has been a dramatic increase in the incidence of diabetes worldwide, which has been exacerbated by the growing obesity problem across the globe. Once thought of as primarily a childhood disease - sometimes referred to as juvenile diabetes, now mostly Type 1 diabetes - the obesity crisis linked to the adoption of a high-fat, high-carbohydrate, high-calorie American diet has resulted in skyrocketing rates of diabetes, particularly Type 2 diabetes, among adults across the world. As such, the global market for blood glucose testing products is undergoing a significant transition driven by the advent of new analytical technologies and developments in diabetes treatment. Although the blood glucose testing segment of the in vitro diagnostics (IVD) industry is mature, certain segments of the market, such as home testing devices for diabetes management, will exhibit strong growth. What's more, non-invasive testing now represents a major new area for the application of IVD testing. Additionally, direct access testing - or over-the-counter testing, which allows consumers to order tests themselves without visiting a doctor`- has emerged as a strong force in the blood glucose testing segment.

The purpose of this TriMark Publications report is to describe the specific market segments for blood glucose testing and diabetes management. This study reviews all of the generally-accepted clinical analytical methods that are currently in use today for measuring serum or plasma or whole-blood glucose concentrations. Moreover, it examines clinical measurement devices, reagents and supplies as utilized in hospitals, clinics, doctor's offices and at-home care locations.

Key Topics Covered:

1. Overview

2. Diabetes

3. Market Analysis: Size, Growth, Share and Competitors

4. Glucose Diagnostic and Monitoring Recommendations

5. Glucose Testing Technology Platforms and Consumable Products

6. Glucose Testing Devices on the Market

7. Business Trends in Glucose Testing

8. Technology Trends

9. Company Profiles

Companies Mentioned:

- Abaxis, Inc.

- Abbott Laboratories

- ACON Laboratories

- AgaMatrix

- Alere

- All Medicus

- Amedica Biotech

- A. Menarini Diagnostics

- Apex Biotechnology Corporation

- ARKRAY

- Bayer

- B. Braun Melsungen

- Beckman Coulter

- Bionime

- Bio-Rad Laboratories, Inc.

- BioTex

- Calisto Medical

- Cambridge Sensors

- DexCom

- Diagnostic Devices/Prodigy Diabetes Care

- DiaSys

- Echo Therapeutics

- Entra Health Systems

- Fora Care

- Genesis Health Technologies

- GenExel-Sein

- GlucoPlus

- GluMetris

- GlySens

- Hainice Medical

- HemoCue (a Quest Diagnostics company)

- Home Diagnostics

- Infopia

- IN4 Technology

- International Techidyne Corporation (ITC)

- Instrumentation Laboratory Company

- i-Sens

- Johnson & Johnson

- Luminous Medical

- Medtronic

- Nipro Corporation

- Nova Biomedical

- OrSense

- Polymer Technology Systems

- Radiometer Medical

- Roche

- 77 Elektronika Kft.

- Siemens AG

- Smiths Group

- Stanbio Laboratory

- TaiDoc Technology

- Techno Medica Co., Ltd.

- US Diagnostics

- VeraLight

For more information visit http://www.researchandmarkets.com/research/j49msm/blood_glucose

Research and Markets
Laura Wood , Senior Manager,
press@researchandmarkets.com
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716


'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. China Cord Blood Corporation Received AABB Accreditation
2. Cellular Therapy and Cord Blood 2013 Market Report
3. Stem Cell / Regenerative Medicine & HSCT / Cord Blood Market Analysis in New Research Report at ReportsnReports.com
4. Array Biopharma and Global Blood Therapeutics Announce Drug Discovery Collaboration Focused on Hematology
5. China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2013
6. Dr. Carlos Szajnert, Announced today his Commitment to Further Educate his Patients on the Benefits of Cord Blood Stem Cells
7. UCLA researchers further refine NanoVelcro device to grab single cancer cells from blood
8. The Leukemia & Lymphoma Society: Impacting Blood Cancers and Beyond
9. China Cord Blood Corporation to Report Third Quarter and First Nine Months of Fiscal 2013 Financial Results
10. Cellular Therapy Market and Cord Blood Market 2013 Industry Research Report: MarketResearchReports.Biz
11. China Cord Blood Corporation Announces Completion of Corporate Structure Consolidation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2017)... ... 27, 2017 , ... Arrowhead Publishers is pleased to announce ... to San Diego, CA on September 27-28, 2017. Leaders from the pharmaceutical, biotech, ... in the treatment of various types of pain. There are also extended networking ...
(Date:4/27/2017)... (PRWEB) , ... April 27, 2017 , ... ... the 2017 Borlaug CAST Communication Award goes to Jayson Lusk, a consummate communicator ... forms of media to advocate for science, as he explains how innovation and ...
(Date:4/26/2017)... ... April 26, 2017 , ... Led by ... I clinical trials comes to Tampa, San Francisco and Boston in 2017. ... FDA regulated organizations such as Pfizer Inc., Teva Pharmaceuticals, Advaxis, Inc., Ocular Therapeutix ...
(Date:4/26/2017)... 26, 2017  Genisphere LLC, provider of the ... a collaborative and sponsored research agreement with the ... . The overall goal of the partnership is ... 3DNA designs and formulations after in vivo ... the vasculature as well as inflammatory responses, demonstrating ...
Breaking Biology Technology:
(Date:4/13/2017)... , April 13, 2017 According to a new ... Authentication, Identity Analytics, Identity Administration, and Authorization), Service, Authentication Type, Deployment Mode, ... IAM Market is expected to grow from USD 14.30 Billion in 2017 ... (CAGR) of 17.3%. ... MarketsandMarkets Logo ...
(Date:4/11/2017)... 2017 NXT-ID, Inc. (NASDAQ:   NXTD ... the appointment of independent Directors Mr. Robin D. Richards ... of Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , Chief ... to their guidance and benefiting from their considerable expertise as ...
(Date:4/5/2017)... KEY FINDINGS The global market ... CAGR of 25.76% during the forecast period of 2017-2025. ... for the growth of the stem cell market. ... MARKET INSIGHTS The global stem cell market is segmented ... The stem cell market of the product is segmented ...
Breaking Biology News(10 mins):